Study sheds light on how psychiatric risk gene disrupts brain development

Jul 14, 2010

Scientists are making progress towards a better understanding of the neuropathology associated with debilitating psychiatric illnesses like bipolar disorder and schizophrenia. New research, published by Cell Press in the July 15 issue of the journal Neuron, reveals mechanisms that connect a known psychiatric risk gene to disruptions in brain cell proliferation and migration during development.

A research group led by Dr. Li-Huei Tsai from the Massachusetts Institute of Technology had recently discovered that the psychiatric risk gene, Disrupted in Schizophrenia-1 (DISC1), is an essential regulator of the proliferation of early (known as neural progenitor cells) via inhibition of a molecule called GSK3? and modulation of the Wnt signaling pathway. Disruptions in the Wnt pathway, which is critical for , have previously been linked with developmental defects and with various human diseases.

"Our recent finding was particularly interesting because one of the actions of lithium, the most common drug, is to inhibit GSK3?." explains Dr. Tsai. "Although DISC1 was one of the first risk genes to be identified and we know that it plays a key role in , the mechanisms by which DISC1 is regulated remain unknown." In this study, Dr. Tsai and colleagues built on earlier work and investigated how DISC1 is regulated during cortical development by looking for novel DISC1-interacting proteins.

The researchers discovered a key interaction between DISC1 and a protein called Dixdc1 which is the mammalian version of a nonmammalian Wnt signaling molecule. Dixdc1 and DISC1 interacted to regulate neural progenitor proliferation via modulation of Wnt/GSK3? signaling. Interestingly, although DISC1 and Dixdc1 were both essential for neural migration, the Wnt/GSK3? pathway was not required for migration. It appears as if Dixdc1 integrates DISC1 into Wnt-dependent and -independent signaling pathways.

"Our findings identify the novel Wnt signaling pathway gene, Dixdc1, as a critical regulator of DISC1 function during cortical development. This discovery suggests that Dixdc1 and DISC1 are involved in Wnt signaling at many levels in the nervous system and that mutations in DISC1 likely contribute to disease pathology by disrupting Wnt signaling during neural development and in the adult brain," concludes Dr. Tsai. "Future studies are needed to determine whether other candidate psychiatric risk genes also interact with Wnt signaling."

Explore further: Neuroscientists watch imagination happening in the brain

More information: Singh et al.: “Dixdc1 Is a Critical Regulator of DISC1 and Embryonic Cortical Development.” Publishing in Neuron 67, 33-48, July 15, 2010. DOI 10.1016/j.neuron.2010.06.002

Related Stories

Schizophrenia-linked gene controls the birth of new neurons

Mar 19, 2009

A gene that is arguably the most studied "schizophrenia gene" plays an unanticipated role in the brain: It controls the birth of new neurons in addition to their integration into existing brain circuitry, according to a report ...

Building the blood-brain barrier

Oct 27, 2008

Construction of the brain's border fence is supervised by Wnt/b-catenin signaling, report Liebner et al. in The Journal of Cell Biology.

A genetic basis for schizophrenia

Jul 21, 2009

Schizophrenia is a severely debilitating psychiatric disease that is thought to have its roots in the development of the nervous system; however, major breakthroughs linking its genetics to diagnosis, prognosis and treatment ...

Stem cell research uncovers mechanism for type 2 diabetes

Feb 12, 2009

Taking clues from their stem cell research, investigators at the University of California San Diego (UC San Diego) and Burnham Institute for Medical Research (Burnham) have discovered that a signaling pathway involved in ...

Progress toward new therapies for coronary artery disease

Nov 08, 2007

Coronary artery disease is a leading cause of mortality in Western countries. It cannot be cured. Recent research, led by Pilar Ruiz-Lozano, Ph.D., at the Burnham Institute for Medical Research, may lead to new therapies ...

Recommended for you

Xenon exposure shown to erase traumatic memories

19 hours ago

McLean Hospital researchers are reporting that xenon gas, used in humans for anesthesia and diagnostic imaging, has the potential to be a treatment for post-traumatic stress disorder (PTSD) and other memory-related disorders.

Stop and listen: Study shows how movement affects hearing

20 hours ago

When we want to listen carefully to someone, the first thing we do is stop talking. The second thing we do is stop moving altogether. This strategy helps us hear better by preventing unwanted sounds generated ...

User comments : 0